首页 | 本学科首页   官方微博 | 高级检索  
检索        

2017-2020年某院临床分离耐碳青霉烯阴沟肠杆菌检测及分析
引用本文:侯辰蕊,陈东科,戎建荣,李亚楠,周永年,栗子洋,董怡然.2017-2020年某院临床分离耐碳青霉烯阴沟肠杆菌检测及分析[J].中国抗生素杂志,2022,47(1):94-102.
作者姓名:侯辰蕊  陈东科  戎建荣  李亚楠  周永年  栗子洋  董怡然
作者单位:山西白求恩医院(山西医学科学院同济山西医院);卫生部北京医院检验科
基金项目:山西省卫生健康委面上项目(No.2020012);山西省科技厅面上项目(No.201901D111420)。
摘    要:摘要:目的 通过研究本院近3年耐碳青霉烯阴沟肠杆菌,探讨其临床分布及相关耐药基因分布情况。方法 收集2017年1月至2020年9月山西白求恩医院分离的33株耐碳青霉烯阴沟肠杆菌为研究对象,利用全自动快速生物质谱检测系统(美国Bruker,MicroflexLT/SH)进行细菌鉴定,VITEK2-Compact全自动微生物分析系统进行细菌药敏试验。采用改良碳青霉烯灭活试验进行耐药表型筛选。采用PCR方法检测碳青霉烯酶基因(blaIMP、blaKPC、blaNDM 、blaVIM和blaOXA-48)。对所有菌株进行MLST分型和同源性分析。质粒接合转移实验研究耐药质粒的传播。结果 22株阴沟肠杆菌对厄他培南、亚胺培南、美罗培南均耐药,11株仅对厄他培南耐药。其中16株阴沟肠杆菌产NDM-1,4株产NDM-5,2株产IPM-1,1株菌同时产NDM-1和KPC-2。11株仅对厄他培南耐药阴沟肠杆菌中有两株检出blaNDM-1、两株检出blaKPC-2基因。MLST分型主要流行株为ST418型。质粒接合转移实验有14株转移成功。结论 本院耐碳青霉烯类阴沟肠杆菌从2017年逐年增加,2020年出现暴发流行。携带的碳青霉烯酶基因以blaNDM为主,ST418型菌株占多数。耐药基因可通过质粒水平传播,所以加强临床耐药菌株筛检及控制对临床抗感染治疗作用关键。

关 键 词:阴沟肠杆菌  碳青霉烯酶  基因型  耐药性  

Hospital laboratory study of carbapenem-resistant Enterobacter cloacae from 2017 to 2020
Hou Chen-rui,Chen Dong-ke,Rong Jian-rong,Li Ya-nan,Zhou Yong-nian,Li Zi-yang,Dong Yi-ran.Hospital laboratory study of carbapenem-resistant Enterobacter cloacae from 2017 to 2020[J].Chinese Journal of Antibiotics,2022,47(1):94-102.
Authors:Hou Chen-rui  Chen Dong-ke  Rong Jian-rong  Li Ya-nan  Zhou Yong-nian  Li Zi-yang  Dong Yi-ran
Institution:(Laboratory department of Shanxi Bethune hospital(Shanxi Academy of Medical Sciences,Tongji Shanxi Hospital),Third Hospital of Shanxi Medical University,Taiyuan 030032;Laboratory department of Beijing hospital,Beijing 100730)
Abstract:Abstract Objective To investigate the clinical distribution and drug resistance gene distribution of carbapenem resistant Enterobacter cloacae in our hospital in recent three years. Methods 33 strains of carbapenem resistant Enterobacter cloacae isolated from Shanxi Bethune hospital from January 2017 to September 2020 were selected as the research objects. The bacteria were identified by MALDI-TOF(Bruker, microflexlt / SH), and the bacterial susceptibility test was carried out by automatic microbial analysis system compact vitek2. Modified carbapenem inactivation test was used to screen resistant phenotypes. Carbapenemase genes (blaIMP, blaKPC, blaNDM, blaVIM, and blaOXA-48) were detected by PCR. MLST typing and homology analysis were performed on all strains. Plasmid conjugation transfer assay was used to study the transmission of drug-resistant plasmids. Results 22 strains of Enterobacter cloacae were resistant to ertapenem, imipenem and meropenem, and 11 strains were only resistant to ertapenem. Among them, 16 strains produced NDM-1, 4 strains produced NDM-5, 2 strains produced IPM-1 and 1 strain produced both NDM-1 and KPC-2. blaNDM-1 and blaKPC-2 genes were detected in two of 11 strains of Enterobactercloacae resistant to ertapenem. The main epidemic strain of MLST was ST418. 14 strains were successfully transferred by plasmid conjugation. Conclusion The number of carbapenem resistant Enterobacter cloacae in our hospital increased since 2017, and an outbreak in 2020. Main carbapenemase gene is blaNDM, and ST418. Drug resistant genes can be transmitted in plasmid level, so that strengthening the screening and control of clinical drug-resistant strains is the key to clinical infection
Keywords:Enterobacter cloacae  Carbapenems  Genotype  Drug resistance
本文献已被 维普 等数据库收录!
点击此处可从《中国抗生素杂志》浏览原始摘要信息
点击此处可从《中国抗生素杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号